Literature DB >> 14636156

Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma.

Xiao-Dong Zhou1, Jie-Ping Yu, Jin Liu, He-Sheng Luo, Hong-Xia Chen, Hong-Gang Yu.   

Abstract

The aim of the present study was to investigate the prevalence of c-FLIP [cellular FLICE-inhibitory protein, where FLICE is Fas-associated death domain (FADD)-like interleukin-1beta-converting enzyme] expression in gastric adenocarcinoma and its possible implications for the progression of the cancer. Expression of c-FLIP in 48 gastric adenocarcinomas and their normal counterparts was analysed by reverse transcriptase PCR, Western blotting and immunohistochemistry. In situ cell apoptosis was detected by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling) assay. As a result, c-FLIP transcripts were constitutively expressed in gastric adenocarcinomas and their levels were significantly higher than those in matched normal tissues ( P < 0.01). Immunohistochemically, the c-FLIP protein was also found to be expressed in all gastric adenocarcinomas (48/48), and 68.8% (33/48) showed an intense immunostaining; in contrast, only 75% (36/48) of normal gastric mucosa showed positive staining and none of them immunostained intensely. The abundance of c-FLIP protein was significantly higher in carcinoma than in normal gastric mucosa (6.93 +/- 0.58 versus 3.19 +/- 0.26, P < 0.01) and showed a reverse correlation with apoptotic index in adenocarcinoma, but not in normal mucosa. In addition, abundance of c-FLIP was significantly associated with lymph node metastasis at both mRNA level ( P < 0.05) and protein level ( P < 0.01). Western-blot analysis showed that the expression levels of the long form of c-FLIP and the short form of c-FLIP in adenocarcinomas were 2.6-fold and 2.8-fold ( P < 0.01) higher than those in normal tissues respectively. However, no significant difference was found between the expression levels of the two isoforms in both adenocarcinomas or normal tissues. In conclusion, overexpression of c-FLIP is tumour specific, which may be one of the in vivo mechanisms by which tumour cells escape from apoptotic death during the malignant transformation, and plays an important role in lymph node metastasis of gastric adenocarcinoma, which ultimately contributes to the tumour progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14636156     DOI: 10.1042/CS20030238

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  24 in total

1.  Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.

Authors:  A C West; K Tang; H Tye; L Yu; N Deng; M Najdovska; S J Lin; J J Balic; E Okochi-Takada; P McGuirk; B Keogh; W McCormack; P S Bhathal; M Reilly; M Oshima; T Ushijima; P Tan; B J Jenkins
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

2.  Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates.

Authors:  Ravi S Misra; Dawn M Jelley-Gibbs; Jennifer Q Russell; Gail Huston; Susan L Swain; Ralph C Budd
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

3.  Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer.

Authors:  Xiao-Dong Zhou; Jie-Ping Yu; Hong-Xia Chen; Hong-Gang Yu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 4.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

5.  Multiple Functions of Cellular FLIP Are Essential for Replication of Hepatitis B Virus.

Authors:  Ah Ram Lee; Keo-Heun Lim; Eun-Sook Park; Doo Hyun Kim; Yong Kwang Park; Soree Park; Dong-Sik Kim; Gu-Choul Shin; Hong Seok Kang; Juhee Won; Heewoo Sim; Yea Na Ha; Byeongjune Jae; Seong Il Choi; Kyun-Hwan Kim
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis.

Authors:  Shi-Yong Sun
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

Review 7.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

8.  Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations.

Authors:  Xiuguo Li; Xinliang Pan; Hui Zhang; Dapeng Lei; Dayu Liu; Fenglei Xu; Xinyong Luan
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-09       Impact factor: 4.553

9.  Genetic variants in fas signaling pathway genes and risk of gastric cancer.

Authors:  Paula L Hyland; Shih-Wen Lin; Nan Hu; Han Zhang; Lemin Wang; Hua Su; Chaoyu Wang; Ti Ding; Ze-Zhong Tang; Jin-Hu Fan; You-Lin Qiao; Xiaoqin Xiong; William Wheeler; Carol Giffen; Kai Yu; Jeff Yuenger; Laurie Burdett; Zhaoming Wang; Stephen J Chanock; Margaret A Tucker; Sanford M Dawsey; Neal D Freedman; Alisa M Goldstein; Christian C Abnet; Philip R Taylor
Journal:  Int J Cancer       Date:  2013-09-11       Impact factor: 7.396

Review 10.  FLIP as an anti-cancer therapeutic target.

Authors:  Jin Kuk Yang
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.